Peer-Reviewed Publications

CPCE investigators are international experts in their clinical effectiveness-related fields, and have authored hundreds of pediatric research articles in leading peer-reviewed journals. From here you can access CPCE journal article abstracts by author, title, or year.

Found 163 results
Author [ Title(Desc)] Year
Filters: Author is Aplenc, Richard  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
Lamba JK, Voigt AP, Chauhan L, et al. "CD33 splicing SNP regulates expression levels of CD33 in normal regenerating monocytes in AML patients." Leuk. Lymphoma. 2018:1-4.
Tarlock K, Lamble A, Wang J, et al. "CEBPA bZip Mutations are Associated with Favorable Prognosis in de novo AML: A Report from the Children's Oncology Group." Blood. 2021.
O'Connor MJ, Zhang X, Griffis H, et al. "Center Variation in Indication and Short-Term Outcomes after Pediatric Heart Transplantation: Analysis of a Merged United Network for Organ Sharing - Pediatric Health Information System Cohort." Pediatr Cardiol. 2021.
Miller TP, Li Y, Kavcic M, et al. "Center-level variation in accuracy of adverse event reporting in a clinical trial for pediatric acute myeloid leukemia: A report from the Children's Oncology Group." Haematologica. 2017.
Johnston DL, Alonzo TA, Gerbing RB, et al. "Central nervous system disease in pediatric acute myeloid leukemia: A report from the Children's Oncology Group." Pediatr Blood Cancer. 2017.
Miller TP, Marx MZ, Henchen C, et al. "Challenges and Barriers to Adverse Event Reporting in Clinical Trials: A Children's Oncology Group Report." J Patient Saf. 2021.
Maude SL, Frey N, Shaw PA, et al. "Chimeric antigen receptor T cells for sustained remissions in leukemia." N. Engl. J. Med.. 2014;371(16):1507-17.
Grupp SA, Kalos M, Barrett D, et al. "Chimeric antigen receptor-modified T cells for acute lymphoid leukemia." N. Engl. J. Med.. 2013;368(16):1509-18.
Lalonde E, Rentas S, Wertheim G, et al. "Clinical impact of genomic characterization of 15 patients with acute megakaryoblastic leukemia-related malignancies." Cold Spring Harb Mol Case Stud. 2021;7(2).
Hoff FW, van Dijk AD, Qiu Y, et al. "Clinical relevance of proteomic profiling in de novo pediatric acute myeloid leukemia: a Children's Oncology Group study." Haematologica. 2022.
Arnold SD, Brazauskas R, He N, et al. "Clinical risks and healthcare utilization of haematopoietic cell transplantation for sickle cell disease in the U.S. using merged databases." Haematologica. 2017;102(11):1823-1832.
Surrey LF, MacFarland SP, Chang F, et al. "Clinical utility of custom-designed NGS panel testing in pediatric tumors." Genome Med. 2019;11(1):32.
Luskin M, Wertheim G, Morrissette J, et al. "CLL/SLL diagnosed in an adolescent." Pediatr Blood Cancer. 2014;61(6):1107-10.
C Zwaan M, Kolb EA, Reinhardt D, et al. "Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia." J. Clin. Oncol.. 2015;33(27):2949-62.
Li Y, Newton JG, Getz KD, et al. "Comparable on-therapy mortality and supportive care requirements in Black and White patients following initial induction for pediatric acute myeloid leukemia." Pediatr Blood Cancer. 2018:e27583.
Vujkovic M, Aplenc R, Alonzo TA, Gamis AS, Li Y. "Comparing Analytic Methods for Longitudinal GWAS and a Case-Study Evaluating Chemotherapy Course Length in Pediatric AML. A Report from the Children's Oncology Group." Front Genet. 2016;7:139.
Miller TP, Troxel AB, Li Y, et al. "Comparison of administrative/billing data to expected protocol-mandated chemotherapy exposure in children with acute myeloid leukemia: A report from the Children's Oncology Group." Pediatr Blood Cancer. 2015;62(7):1184-9.
Miller TP, Getz KD, Kavcic M, et al. "A comparison of discharge strategies after chemotherapy completion in pediatric patients with acute myeloid leukemia: a report from the Children's Oncology Group." Leuk. Lymphoma. 2016:1-8.
Getz KD, Li Y, Alonzo TA, et al. "Comparison of in-patient costs for children treated on the AAML0531 clinical trial: A report from the Children's Oncology Group." Pediatr Blood Cancer. 2015;62(10):1775-81.
Getz KD, Miller TP, Seif AE, et al. "A comparison of resource utilization following chemotherapy for acute myeloid leukemia in children discharged versus children that remain hospitalized during neutropenia." Cancer Med. 2015;4(9):1356-64.
Winestone LE, Getz KD, Miller TP, et al. "Complications preceding early deaths in Black and White children with acute myeloid leukemia." Pediatr Blood Cancer. 2017.
Smith JL, Ries RE, Hylkema T, et al. "Comprehensive Transcriptome Profiling of Cryptic CBFA2T3-GLIS2 Fusion-positive AML Defines Novel Therapeutic Options - A COG and TARGET Pediatric AML Study." Clin. Cancer Res.. 2019.
Vujkovic M, Attiyeh EF, Ries RE, et al. "Concordance of copy number alterations using a common analytic pipeline for genome-wide analysis of Illumina and Affymetrix genotyping data: a report from the Children's Oncology Group." Cancer Genet. 2015;208(7-8):408-13.
DiNofia AM, Seif AE, Devidas M, et al. "Cost comparison by treatment arm and center-level variations in cost and inpatient days on the phase III high-risk B acute lymphoblastic leukemia trial AALL0232." Cancer Med. 2018;7(1):3-12.
Citrin R, Horowitz JP, Reilly AF, et al. "Creation of a pediatric mature B-cell non-Hodgkin lymphoma cohort within the Pediatric Health Information System Database." PLoS ONE. 2017;12(10):e0186960.

Pages